In this episode, Dr. Cedric O’Gorman, from Axsome Therapeutics, reports on efficacy and safety data for their pipeline acute medication, AXS-07, which is a combination of the NSAID meloxicam and rizatriptan.
*The contents of this podcast are intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. AMD and the speaker do not recommend or endorse any specific course of treatment, products, procedures, opinions, or other information that may be mentioned. Reliance on any information provided by this content is solely at your own risk.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
